nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0726	0.149	CbGbCtD
Morphine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0611	0.125	CbGbCtD
Morphine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0611	0.125	CbGbCtD
Morphine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0545	0.112	CbGbCtD
Morphine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0513	0.105	CbGbCtD
Morphine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0346	0.0711	CbGbCtD
Morphine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.033	0.0678	CbGbCtD
Morphine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0294	0.0604	CbGbCtD
Morphine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0288	0.0592	CbGbCtD
Morphine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0272	0.0559	CbGbCtD
Morphine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0173	0.0355	CbGbCtD
Morphine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0163	0.0335	CbGbCtD
Morphine—Galantamine—CHRNA5—chronic obstructive pulmonary disease	0.00449	0.454	CrCbGaD
Morphine—Naloxone—TLR4—chronic obstructive pulmonary disease	0.00293	0.296	CrCbGaD
Morphine—Galantamine—CHRNA3—chronic obstructive pulmonary disease	0.0021	0.213	CrCbGaD
Morphine—Naloxone—ALB—chronic obstructive pulmonary disease	0.000366	0.037	CrCbGaD
Morphine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000332	0.001	CcSEcCtD
Morphine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.001	CcSEcCtD
Morphine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.000992	CcSEcCtD
Morphine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.000992	CcSEcCtD
Morphine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.000992	CcSEcCtD
Morphine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000989	CcSEcCtD
Morphine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.000989	CcSEcCtD
Morphine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000328	0.000988	CcSEcCtD
Morphine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.000988	CcSEcCtD
Morphine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000328	0.000987	CcSEcCtD
Morphine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000987	CcSEcCtD
Morphine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000987	CcSEcCtD
Morphine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000326	0.000983	CcSEcCtD
Morphine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.000983	CcSEcCtD
Morphine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.000981	CcSEcCtD
Morphine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00098	CcSEcCtD
Morphine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000325	0.000979	CcSEcCtD
Morphine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.000979	CcSEcCtD
Morphine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000324	0.000975	CcSEcCtD
Morphine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.000971	CcSEcCtD
Morphine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000969	CcSEcCtD
Morphine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000321	0.000968	CcSEcCtD
Morphine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000321	0.000966	CcSEcCtD
Morphine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.000966	CcSEcCtD
Morphine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00032	0.000964	CcSEcCtD
Morphine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000318	0.000959	CcSEcCtD
Morphine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000955	CcSEcCtD
Morphine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000951	CcSEcCtD
Morphine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000951	CcSEcCtD
Morphine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000945	CcSEcCtD
Morphine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000312	0.000941	CcSEcCtD
Morphine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.000941	CcSEcCtD
Morphine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.000937	CcSEcCtD
Morphine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.000936	CcSEcCtD
Morphine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.000935	CcSEcCtD
Morphine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.000933	CcSEcCtD
Morphine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.000929	CcSEcCtD
Morphine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.000924	CcSEcCtD
Morphine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00092	CcSEcCtD
Morphine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00092	CcSEcCtD
Morphine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000305	0.000918	CcSEcCtD
Morphine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.000918	CcSEcCtD
Morphine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000302	0.000911	CcSEcCtD
Morphine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.000911	CcSEcCtD
Morphine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.000907	CcSEcCtD
Morphine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000301	0.000906	CcSEcCtD
Morphine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000298	0.000899	CcSEcCtD
Morphine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.000898	CcSEcCtD
Morphine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000298	0.000898	CcSEcCtD
Morphine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000297	0.000896	CcSEcCtD
Morphine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.000896	CcSEcCtD
Morphine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000296	0.000893	CcSEcCtD
Morphine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.000889	CcSEcCtD
Morphine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000887	CcSEcCtD
Morphine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000887	CcSEcCtD
Morphine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000294	0.000886	CcSEcCtD
Morphine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.000883	CcSEcCtD
Morphine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000878	CcSEcCtD
Morphine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000291	0.000877	CcSEcCtD
Morphine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.000875	CcSEcCtD
Morphine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00087	CcSEcCtD
Morphine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00087	CcSEcCtD
Morphine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000869	CcSEcCtD
Morphine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000288	0.000869	CcSEcCtD
Morphine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.000869	CcSEcCtD
Morphine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.000867	CcSEcCtD
Morphine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000286	0.000862	CcSEcCtD
Morphine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000286	0.000862	CcSEcCtD
Morphine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.000862	CcSEcCtD
Morphine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.000862	CcSEcCtD
Morphine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00086	CcSEcCtD
Morphine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000859	CcSEcCtD
Morphine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.000854	CcSEcCtD
Morphine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000283	0.000852	CcSEcCtD
Morphine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000282	0.000851	CcSEcCtD
Morphine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.000848	CcSEcCtD
Morphine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000846	CcSEcCtD
Morphine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00028	0.000844	CcSEcCtD
Morphine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.000842	CcSEcCtD
Morphine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000837	CcSEcCtD
Morphine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.000835	CcSEcCtD
Morphine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.000834	CcSEcCtD
Morphine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.000832	CcSEcCtD
Morphine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00083	CcSEcCtD
Morphine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00083	CcSEcCtD
Morphine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.000829	CcSEcCtD
Morphine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.000827	CcSEcCtD
Morphine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.000826	CcSEcCtD
Morphine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.000824	CcSEcCtD
Morphine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000273	0.000824	CcSEcCtD
Morphine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000823	CcSEcCtD
Morphine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.000821	CcSEcCtD
Morphine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00082	CcSEcCtD
Morphine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.000814	CcSEcCtD
Morphine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.000814	CcSEcCtD
Morphine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000268	0.000807	CcSEcCtD
Morphine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000807	CcSEcCtD
Morphine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.0008	CcSEcCtD
Morphine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000266	0.0008	CcSEcCtD
Morphine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000264	0.000796	CcSEcCtD
Morphine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000264	0.000796	CcSEcCtD
Morphine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.000796	CcSEcCtD
Morphine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.000796	CcSEcCtD
Morphine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000794	CcSEcCtD
Morphine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.000794	CcSEcCtD
Morphine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000788	CcSEcCtD
Morphine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.000787	CcSEcCtD
Morphine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.000786	CcSEcCtD
Morphine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.000786	CcSEcCtD
Morphine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00026	0.000784	CcSEcCtD
Morphine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.000784	CcSEcCtD
Morphine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.000782	CcSEcCtD
Morphine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.000782	CcSEcCtD
Morphine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00078	CcSEcCtD
Morphine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00078	CcSEcCtD
Morphine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000778	CcSEcCtD
Morphine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000767	CcSEcCtD
Morphine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000764	CcSEcCtD
Morphine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.000756	CcSEcCtD
Morphine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000752	CcSEcCtD
Morphine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000752	CcSEcCtD
Morphine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.000742	CcSEcCtD
Morphine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000246	0.000742	CcSEcCtD
Morphine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.000742	CcSEcCtD
Morphine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00074	CcSEcCtD
Morphine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000739	CcSEcCtD
Morphine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000734	CcSEcCtD
Morphine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000241	0.000727	CcSEcCtD
Morphine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00024	0.000723	CcSEcCtD
Morphine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.000723	CcSEcCtD
Morphine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000237	0.000713	CcSEcCtD
Morphine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.000713	CcSEcCtD
Morphine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000235	0.000708	CcSEcCtD
Morphine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000702	CcSEcCtD
Morphine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000701	CcSEcCtD
Morphine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000698	CcSEcCtD
Morphine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.000689	CcSEcCtD
Morphine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000229	0.000689	CcSEcCtD
Morphine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.000683	CcSEcCtD
Morphine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000679	CcSEcCtD
Morphine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000224	0.000675	CcSEcCtD
Morphine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000673	CcSEcCtD
Morphine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000669	CcSEcCtD
Morphine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.000666	CcSEcCtD
Morphine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000221	0.000666	CcSEcCtD
Morphine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000217	0.000653	CcSEcCtD
Morphine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.000651	CcSEcCtD
Morphine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000642	CcSEcCtD
Morphine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.000641	CcSEcCtD
Morphine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000213	0.000641	CcSEcCtD
Morphine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.000635	CcSEcCtD
Morphine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000211	0.000635	CcSEcCtD
Morphine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.000635	CcSEcCtD
Morphine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000211	0.000635	CcSEcCtD
Morphine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.000631	CcSEcCtD
Morphine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000209	0.000631	CcSEcCtD
Morphine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000631	CcSEcCtD
Morphine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00063	CcSEcCtD
Morphine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000629	CcSEcCtD
Morphine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000629	CcSEcCtD
Morphine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000208	0.000627	CcSEcCtD
Morphine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000207	0.000622	CcSEcCtD
Morphine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000206	0.000622	CcSEcCtD
Morphine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00062	CcSEcCtD
Morphine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000205	0.000618	CcSEcCtD
Morphine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.000605	CcSEcCtD
Morphine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.000603	CcSEcCtD
Morphine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.000601	CcSEcCtD
Morphine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.0006	CcSEcCtD
Morphine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.0006	CcSEcCtD
Morphine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.000599	CcSEcCtD
Morphine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.000598	CcSEcCtD
Morphine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000199	0.000598	CcSEcCtD
Morphine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.000596	CcSEcCtD
Morphine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000588	CcSEcCtD
Morphine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000195	0.000586	CcSEcCtD
Morphine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000579	CcSEcCtD
Morphine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000577	CcSEcCtD
Morphine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000568	CcSEcCtD
Morphine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000565	CcSEcCtD
Morphine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000562	CcSEcCtD
Morphine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000555	CcSEcCtD
Morphine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000548	CcSEcCtD
Morphine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000546	CcSEcCtD
Morphine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000546	CcSEcCtD
Morphine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.000537	CcSEcCtD
Morphine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.000533	CcSEcCtD
Morphine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000528	CcSEcCtD
Morphine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000522	CcSEcCtD
Morphine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000518	CcSEcCtD
Morphine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000506	CcSEcCtD
Morphine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000494	CcSEcCtD
Morphine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00049	CcSEcCtD
Morphine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000489	CcSEcCtD
Morphine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000486	CcSEcCtD
Morphine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000486	CcSEcCtD
Morphine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000467	CcSEcCtD
Morphine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000458	CcSEcCtD
Morphine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000451	CcSEcCtD
Morphine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00045	CcSEcCtD
Morphine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000449	CcSEcCtD
Morphine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000446	CcSEcCtD
Morphine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000438	CcSEcCtD
Morphine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000437	CcSEcCtD
Morphine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000436	CcSEcCtD
Morphine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000433	CcSEcCtD
Morphine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000427	CcSEcCtD
Morphine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000421	CcSEcCtD
Morphine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000419	CcSEcCtD
Morphine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000414	CcSEcCtD
Morphine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000412	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000411	CcSEcCtD
Morphine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000409	CcSEcCtD
Morphine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000402	CcSEcCtD
Morphine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000397	CcSEcCtD
Morphine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000397	CcSEcCtD
Morphine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000394	CcSEcCtD
Morphine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00039	CcSEcCtD
Morphine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000389	CcSEcCtD
Morphine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000387	CcSEcCtD
Morphine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000385	CcSEcCtD
Morphine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000383	CcSEcCtD
Morphine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000378	CcSEcCtD
Morphine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000361	CcSEcCtD
Morphine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000361	CcSEcCtD
Morphine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000359	CcSEcCtD
Morphine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000356	CcSEcCtD
Morphine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000349	CcSEcCtD
Morphine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000345	CcSEcCtD
Morphine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000344	CcSEcCtD
Morphine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000344	CcSEcCtD
Morphine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000342	CcSEcCtD
Morphine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000342	CcSEcCtD
Morphine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000339	CcSEcCtD
Morphine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000327	CcSEcCtD
Morphine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000324	CcSEcCtD
Morphine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000324	CcSEcCtD
Morphine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000315	CcSEcCtD
Morphine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000313	CcSEcCtD
Morphine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000313	CcSEcCtD
Morphine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.7e-05	0.000292	CcSEcCtD
Morphine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000284	CcSEcCtD
Morphine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000281	CcSEcCtD
Morphine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9e-05	0.000271	CcSEcCtD
Morphine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000262	CcSEcCtD
Morphine—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	8.64e-05	0.000506	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.62e-05	0.000505	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.61e-05	0.000504	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	8.6e-05	0.000503	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.55e-05	0.000501	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.45e-05	0.000495	CbGpPWpGaD
Morphine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000252	CcSEcCtD
Morphine—Rash—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.00025	CcSEcCtD
Morphine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.00025	CcSEcCtD
Morphine—Headache—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000248	CcSEcCtD
Morphine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.23e-05	0.000482	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.23e-05	0.000482	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	8.18e-05	0.000479	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.16e-05	0.000478	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.13e-05	0.000476	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.12e-05	0.000475	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.08e-05	0.000473	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.08e-05	0.000473	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.99e-05	0.000468	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.88e-05	0.000461	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	7.84e-05	0.000459	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.82e-05	0.000458	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.82e-05	0.000458	CbGpPWpGaD
Morphine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000236	CcSEcCtD
Morphine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.76e-05	0.000454	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.67e-05	0.000449	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	7.67e-05	0.000449	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.66e-05	0.000449	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.66e-05	0.000449	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.56e-05	0.000443	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.47e-05	0.000437	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.46e-05	0.000437	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.39e-05	0.000433	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.29e-05	0.000427	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.23e-05	0.000423	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.17e-05	0.00042	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.16e-05	0.000419	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.14e-05	0.000418	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.11e-05	0.000416	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.000414	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	7.03e-05	0.000411	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.97e-05	0.000408	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.86e-05	0.000401	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.84e-05	0.000401	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.8e-05	0.000398	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	6.72e-05	0.000393	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	6.64e-05	0.000389	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.48e-05	0.000379	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.45e-05	0.000378	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.000372	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.36e-05	0.000372	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.33e-05	0.00037	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.23e-05	0.000364	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	6.13e-05	0.000359	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.12e-05	0.000358	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.11e-05	0.000358	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.1e-05	0.000357	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ALB—chronic obstructive pulmonary disease	5.96e-05	0.000349	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.96e-05	0.000349	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.95e-05	0.000348	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.79e-05	0.000339	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.78e-05	0.000338	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.77e-05	0.000338	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	5.71e-05	0.000334	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—NOS3—chronic obstructive pulmonary disease	5.7e-05	0.000334	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	5.69e-05	0.000333	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.65e-05	0.000331	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.65e-05	0.000331	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.55e-05	0.000325	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.48e-05	0.000321	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.46e-05	0.00032	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.45e-05	0.000319	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.38e-05	0.000315	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.31e-05	0.000311	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.23e-05	0.000306	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.22e-05	0.000306	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.22e-05	0.000306	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	5.21e-05	0.000305	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ALB—chronic obstructive pulmonary disease	5.21e-05	0.000305	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ALB—chronic obstructive pulmonary disease	5.21e-05	0.000305	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.16e-05	0.000302	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.01e-05	0.000293	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.99e-05	0.000292	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.98e-05	0.000292	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—NOS3—chronic obstructive pulmonary disease	4.98e-05	0.000292	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.96e-05	0.00029	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.95e-05	0.000289	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.94e-05	0.000289	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.88e-05	0.000285	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.8e-05	0.000281	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.78e-05	0.00028	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.77e-05	0.000279	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.71e-05	0.000276	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.7e-05	0.000275	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.69e-05	0.000274	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.69e-05	0.000274	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.65e-05	0.000272	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.65e-05	0.000272	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.64e-05	0.000272	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.000271	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.62e-05	0.00027	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.61e-05	0.00027	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.53e-05	0.000265	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.42e-05	0.000258	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.41e-05	0.000258	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.36e-05	0.000255	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.34e-05	0.000254	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.33e-05	0.000253	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.24e-05	0.000248	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.23e-05	0.000247	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.21e-05	0.000246	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.19e-05	0.000245	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.11e-05	0.00024	CbGpPWpGaD
Morphine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.05e-05	0.000237	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.05e-05	0.000237	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.04e-05	0.000236	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.02e-05	0.000235	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.01e-05	0.000235	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.95e-05	0.000231	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.94e-05	0.000231	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.9e-05	0.000228	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.82e-05	0.000224	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.82e-05	0.000224	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.82e-05	0.000224	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.77e-05	0.000221	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.74e-05	0.000219	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.72e-05	0.000218	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.68e-05	0.000216	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.67e-05	0.000215	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.67e-05	0.000215	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.55e-05	0.000208	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000204	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.46e-05	0.000202	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.43e-05	0.000201	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.36e-05	0.000197	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.35e-05	0.000196	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.34e-05	0.000195	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.28e-05	0.000192	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.28e-05	0.000192	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.26e-05	0.000191	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.23e-05	0.000189	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.21e-05	0.000188	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.15e-05	0.000184	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.15e-05	0.000184	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.09e-05	0.000181	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.06e-05	0.000179	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.04e-05	0.000178	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.01e-05	0.000176	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3e-05	0.000176	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.99e-05	0.000175	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.95e-05	0.000173	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.95e-05	0.000173	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.93e-05	0.000171	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.92e-05	0.000171	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.84e-05	0.000166	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.81e-05	0.000164	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	2.79e-05	0.000163	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.77e-05	0.000162	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.72e-05	0.000159	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.68e-05	0.000157	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	2.67e-05	0.000156	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.66e-05	0.000156	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.6e-05	0.000152	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.56e-05	0.00015	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.5e-05	0.000146	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.49e-05	0.000146	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.48e-05	0.000145	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.48e-05	0.000145	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.47e-05	0.000145	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.44e-05	0.000143	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.000142	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.38e-05	0.000139	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.38e-05	0.000139	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	2.37e-05	0.000139	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.28e-05	0.000133	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	2.27e-05	0.000133	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.26e-05	0.000133	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.000132	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.25e-05	0.000132	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.000131	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.000131	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.17e-05	0.000127	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.15e-05	0.000126	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.13e-05	0.000125	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.13e-05	0.000125	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.00012	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000119	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.03e-05	0.000119	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.01e-05	0.000118	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000117	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.96e-05	0.000115	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.94e-05	0.000114	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.93e-05	0.000113	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.89e-05	0.000111	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.87e-05	0.000109	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000108	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000107	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.81e-05	0.000106	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.79e-05	0.000105	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.78e-05	0.000104	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.72e-05	0.0001	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.71e-05	0.0001	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-05	9.9e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	9.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.66e-05	9.69e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.63e-05	9.56e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.58e-05	9.26e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.58e-05	9.24e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.58e-05	9.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.51e-05	8.83e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.51e-05	8.81e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.49e-05	8.74e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	8.74e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.47e-05	8.62e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.47e-05	8.58e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.43e-05	8.38e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	8.24e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	8.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.37e-05	8.03e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.35e-05	7.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.34e-05	7.83e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	7.77e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.32e-05	7.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	7.68e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	7.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	7.57e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.29e-05	7.52e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.27e-05	7.44e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	7.18e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.21e-05	7.08e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	7.01e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.18e-05	6.91e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.16e-05	6.77e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.11e-05	6.48e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	6.46e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.09e-05	6.36e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	5.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.01e-05	5.93e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.97e-06	5.84e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.78e-06	5.72e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.71e-06	5.68e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.71e-06	5.68e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.2e-06	5.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.08e-06	5.31e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.89e-06	5.2e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	8.84e-06	5.18e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.46e-06	4.95e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.46e-06	4.95e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.33e-06	4.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.21e-06	4.8e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.02e-06	4.69e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.97e-06	4.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.51e-06	4.4e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.45e-06	3.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	3.05e-05	CbGpPWpGaD
